Adient (ADNT) PT Lowered to $54 at Barclays
Tweet
Share
E-mailGet Alerts ADNT Hot Sheet
Price: $20.18 -0.98%
Rating Summary:
10 Buy, 11 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Rating Summary:
10 Buy, 11 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Join SI Premium – FREE
Barclays analyst Dan Levy lowered the price target on Adient (NYSE: ADNT) to $54.00 (from $57.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Aebi Schmidt Holding AG (AEBI) PT Raised to $17 at DA Davidson Following Q2 Results
- Adient (ADNT) 1400 contracts of September 20 calls
- Cullinan Oncology Inc. (CGEM) PT Raised to $27 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
